194 related articles for article (PubMed ID: 34000253)
1. Pentosan polysulfate maculopathy.
Lindeke-Myers A; Hanif AM; Jain N
Surv Ophthalmol; 2022; 67(1):83-96. PubMed ID: 34000253
[TBL] [Abstract][Full Text] [Related]
2. Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: A Macula Society Collaborative Study.
Jain N; Liao A; Garg SJ; Patel SN; Wykoff CC; Yu HJ; London NJS; Khurana RN; Zacks DN;
Ophthalmol Retina; 2022 Mar; 6(3):219-227. PubMed ID: 34298229
[TBL] [Abstract][Full Text] [Related]
3. Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis.
Wang D; Au A; Gunnemann F; Hilely A; Scharf J; Tran K; Sun M; Kim JH; Sarraf D
Can J Ophthalmol; 2020 Apr; 55(2):116-125. PubMed ID: 31973791
[TBL] [Abstract][Full Text] [Related]
4. Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium.
Pearce WA; Chen R; Jain N
Ophthalmology; 2018 Nov; 125(11):1793-1802. PubMed ID: 29801663
[TBL] [Abstract][Full Text] [Related]
5. Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.
Mukhopadhyay C; Boyce TM; Gehrs KM; Folk JC; Mullins RF; Luo Y; Kreder K; Sohn EH
Asia Pac J Ophthalmol (Phila); 2022 Mar-Apr 01; 11(2):100-110. PubMed ID: 35533330
[TBL] [Abstract][Full Text] [Related]
6. NINE-YEAR PROGRESSION OF PENTOSAN MACULOPATHY WITH MULTIMODAL RETINAL IMAGING.
Santina A; Fogel-Levin M; Abraham N; Sarraf D
Retin Cases Brief Rep; 2023 Nov; 17(6):664-667. PubMed ID: 35344532
[TBL] [Abstract][Full Text] [Related]
7. Pentosan Polysulfate Maculopathy versus Inherited Macular Dystrophies: Comparative Assessment with Multimodal Imaging.
Barnes AC; Hanif AM; Jain N
Ophthalmol Retina; 2020 Dec; 4(12):1196-1201. PubMed ID: 32446908
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic Spectrum of Pentosan Polysulfate Sodium-Associated Maculopathy: A Multicenter Study.
Hanif AM; Armenti ST; Taylor SC; Shah RA; Igelman AD; Jayasundera KT; Pennesi ME; Khurana RN; Foote JE; O'Keefe GA; Yang P; Hubbard GB; Hwang TS; Flaxel CJ; Stein JD; Yan J; Jain N
JAMA Ophthalmol; 2019 Nov; 137(11):1275-1282. PubMed ID: 31486843
[TBL] [Abstract][Full Text] [Related]
9. Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation.
Shah R; Simonett JM; Lyons RJ; Rao RC; Pennesi ME; Jain N
JAMA Ophthalmol; 2020 Aug; 138(8):894-900. PubMed ID: 32644147
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Pentosan Polysulfate Sodium Maculopathy Originally Diagnosed as Pattern Macular Dystrophy.
Case AW; Anderson MJ; Sayomac LE
Optom Vis Sci; 2021 Jun; 98(6):552-556. PubMed ID: 34039907
[TBL] [Abstract][Full Text] [Related]
11. RAPID PENTOSAN POLYSULFATE SODIUM MACULOPATHY PROGRESSION.
Somisetty S; Santina A; Abraham N; Lu A; Morales VR; Sarraf D
Retin Cases Brief Rep; 2023 Nov; 17(6):660-663. PubMed ID: 35385434
[TBL] [Abstract][Full Text] [Related]
12. VISUAL AND ANATOMICAL CHANGES AFTER DRUG CESSATION IN PENTOSAN POLYSULFATE SODIUM-ASSOCIATED MACULOPATHY.
Gupta PR; Grewal DS
Retin Cases Brief Rep; 2023 Sep; 17(5):507-510. PubMed ID: 37643033
[TBL] [Abstract][Full Text] [Related]
13. Pentosan Polysulfate Maculopathy: Prevalence, Spectrum of Disease, and Choroidal Imaging Analysis Based on Prospective Screening.
Wang D; Velaga SB; Grondin C; Au A; Nittala M; Chhablani J; Vupparaboina KK; Gunnemann F; Jung J; Kim JH; Ip M; Sadda S; Sarraf D
Am J Ophthalmol; 2021 Jul; 227():125-138. PubMed ID: 33651989
[TBL] [Abstract][Full Text] [Related]
14. Update on maculopathy secondary to pentosan polysulfate toxicity.
Abou-Jaoude M; Fraser C; Maldonado RS
Curr Opin Ophthalmol; 2021 May; 32(3):233-239. PubMed ID: 33710012
[TBL] [Abstract][Full Text] [Related]
15. POTENTIAL NEW-ONSET CLINICALLY DETECTABLE PENTOSAN POLYSULFATE MACULOPATHY YEARS AFTER DRUG CESSATION.
Barnett JM; Jain N
Retin Cases Brief Rep; 2022 Nov; 16(6):724-726. PubMed ID: 33229920
[TBL] [Abstract][Full Text] [Related]
16. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
Proctor JG
Can J Urol; 2023 Dec; 30(6):11732-11739. PubMed ID: 38104330
[TBL] [Abstract][Full Text] [Related]
17. Nationwide Usage of Pentosan Polysulfate and Practice Patterns of Pentosan Polysulfate Maculopathy Screening in South Korea.
Kim J; Kwon HY; Kim JH; Ahn SJ
Ophthalmol Retina; 2024 Mar; 8(3):246-253. PubMed ID: 37832716
[TBL] [Abstract][Full Text] [Related]
18. Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging.
Christiansen JS; Barnes AC; Berry DE; Jain N
Can J Ophthalmol; 2022 Feb; 57(1):16-22. PubMed ID: 33722504
[TBL] [Abstract][Full Text] [Related]
19. Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort.
Jain N; Li AL; Yu Y; VanderBeek BL
Br J Ophthalmol; 2020 Aug; 104(8):1093-1097. PubMed ID: 31694837
[TBL] [Abstract][Full Text] [Related]
20. Redefining the Spectrum of Pentosan Polysulfate Retinopathy: Multimodal Imaging Findings from a Cross-Sectional Screening Study.
Dieu AC; Whittier SA; Domalpally A; Pak JW; Voland RP; Boyd KM; Gottlieb JL; Crabtree GS; Giles DL; McAchran SE; Mititelu M
Ophthalmol Retina; 2022 Sep; 6(9):835-846. PubMed ID: 35339727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
